Amedeo Smart

Free Medical Literature Service



Breast Cancer

  Free Subscription


1 Am J Clin Pathol
2 Ann Surg Oncol
2 BMC Cancer
2 Br J Cancer
1 Breast Cancer
6 Breast Cancer Res Treat
1 Breast J
2 Cancer Res
7 Clin Breast Cancer
1 Clin Cancer Res
1 Clin Exp Metastasis
1 Eur J Cancer
1 Gene
1 Genes Chromosomes Cancer
1 Int J Cancer
3 Int J Oncol
1 Int J Radiat Oncol Biol Phys
2 NPJ Breast Cancer
1 Oncogene
6 PLoS One

    Am J Clin Pathol

  1. KHOURY T, Zirpoli G, Cohen SM, Geradts J, et al
    Ki-67 Expression in Breast Cancer Tissue Microarrays: Assessing Tumor Heterogeneity, Concordance With Full Section, and Scoring Methods.
    Am J Clin Pathol. 2017;148:108-118.
    >> Share

    Ann Surg Oncol

  2. MCLAUGHLIN SA, Cornell LF, Mussallem DM
    Sexual Function and Breast-Specific Sensuality Remain Important After Breast Cancer Surgery.
    Ann Surg Oncol. 2017 Sep 13. doi: 10.1245/s10434-017-6086.
    >> Share

  3. DONOVAN CA, Giuliano AE
    Evolution of the Staging System in Breast Cancer.
    Ann Surg Oncol. 2017 Sep 8. doi: 10.1245/s10434-017-6035.
    >> Share

    BMC Cancer

  4. HUSSAIN AR, Siraj AK, Ahmed M, Bu R, et al
    XIAP over-expression is an independent poor prognostic marker in Middle Eastern breast cancer and can be targeted to induce efficient apoptosis.
    BMC Cancer. 2017;17:640.
    >> Share

  5. DEB S, Gorringe KL, Pang JB, Byrne DJ, et al
    BRCA2 carriers with male breast cancer show elevated tumour methylation.
    BMC Cancer. 2017;17:641.
    >> Share

    Br J Cancer

  6. KLIMOV S, Rida PC, Aleskandarany MA, Green AR, et al
    Novel immunohistochemistry-based signatures to predict metastatic site of triple-negative breast cancers.
    Br J Cancer. 2017;117:826-834.
    >> Share

  7. OSAKO T, Iwase T, Ushijima M, Yonekura R, et al
    A new molecular-based lymph node staging classification determines the prognosis of breast cancer patients.
    Br J Cancer. 2017 Sep 14. doi: 10.1038/bjc.2017.
    >> Share

    Breast Cancer

    Questions about lower inner zone tumors in early-stage breast cancer.
    Breast Cancer. 2017 Sep 14. doi: 10.1007/s12282-017-0801.
    >> Share

    Breast Cancer Res Treat

  9. KOCHI M, Iwamoto T, Niikura N, Bianchini G, et al
    Tumour-infiltrating lymphocytes (TILs)-related genomic signature predicts chemotherapy response in breast cancer.
    Breast Cancer Res Treat. 2017 Sep 13. doi: 10.1007/s10549-017-4502.
    >> Share

  10. GREGOROWITSCH ML, van den Bongard HJGD, Young-Afat DA, Pignol JP, et al
    Severe depression more common in patients with ductal carcinoma in situ than early-stage invasive breast cancer patients.
    Breast Cancer Res Treat. 2017 Sep 11. doi: 10.1007/s10549-017-4495.
    >> Share

  11. SAUNUS JM, Smart CE, Kutasovic JR, Johnston RL, et al
    Multidimensional phenotyping of breast cancer cell lines to guide preclinical research.
    Breast Cancer Res Treat. 2017 Sep 9. doi: 10.1007/s10549-017-4496.
    >> Share

  12. NIIKURA N, Shimomura A, Fukatsu Y, Sawaki M, et al
    Durable complete response in HER2-positive breast cancer: a multicenter retrospective analysis.
    Breast Cancer Res Treat. 2017 Sep 11. doi: 10.1007/s10549-017-4489.
    >> Share

  13. MASUNAGA N, Kagara N, Motooka D, Nakamura S, et al
    Highly sensitive detection of ESR1 mutations in cell-free DNA from patients with metastatic breast cancer using molecular barcode sequencing.
    Breast Cancer Res Treat. 2017 Sep 13. doi: 10.1007/s10549-017-4487.
    >> Share

  14. ROCQUE GB, Williams CP, Jones MI, Kenzik KM, et al
    Healthcare utilization, Medicare spending, and sources of patient distress identified during implementation of a lay navigation program for older patients with breast cancer.
    Breast Cancer Res Treat. 2017 Sep 12. doi: 10.1007/s10549-017-4498.
    >> Share

    Breast J

  15. TANG HKC, Lee DYH, Thompson I, Ingram JR, et al
    Delayed and localized pemphigus vulgaris after breast cancer radiotherapy.
    Breast J. 2017 Sep 11. doi: 10.1111/tbj.12910.
    >> Share

    Cancer Res

  16. KATZENELLENBOGEN BS, Zhao Y, Laws MJ, Sanabria Guillen V, et al
    Structurally novel antiestrogens elicit differential responses from constitutively active mutant estrogen receptors in breast cancer cells and tumors.
    Cancer Res. 2017 Sep 13. pii: canres.1265.2017.
    >> Share

  17. DETHLEFSEN C, Hansen LS, Lillelund C, Andersen C, et al
    Exercise-Induced Catecholamines Activate the Hippo Tumor Suppressor Pathway to Reduce Risks of Breast Cancer Development.
    Cancer Res. 2017 Sep 8. doi: 10.1158/0008-5472.CAN-16-3125.
    >> Share

    Clin Breast Cancer

  18. WANG Y, Brodsky AS, Xiong J, Lopresti ML, et al
    Stromal Clusterin Expression Predicts Therapeutic Response to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer.
    Clin Breast Cancer. 2017 Aug 19. pii: S1526-8209(17)30349.
    >> Share

  19. CHAO YL, Anders CK
    TYMS Gene Polymorphisms in Breast Cancer Patients Receiving 5-Fluorouracil-Based Chemotherapy.
    Clin Breast Cancer. 2017 Aug 19. pii: S1526-8209(17)30369.
    >> Share

  20. DONG H, Huang Y, Song F, Dai H, et al
    Improved Performance of Adjunctive Ultrasonography After Mammography Screening for Breast Cancer Among Chinese Females.
    Clin Breast Cancer. 2017 Aug 15. pii: S1526-8209(17)30321.
    >> Share

  21. CHOI WJ, Kim WK, Shin HJ, Cha JH, et al
    Evaluation of the Tumor Response After Neoadjuvant Chemotherapy in Breast Cancer Patients: Correlation Between Dynamic Contrast-enhanced Magnetic Resonance Imaging and Pathologic Tumor Cellularity.
    Clin Breast Cancer. 2017 Aug 18. pii: S1526-8209(17)30058.
    >> Share

  22. CHEN W, Huang Y, Lewis GD, Szeja SS, et al
    Treatment Outcomes and Prognostic Factors in Male Patients With Stage IV Breast Cancer: A Population-based Study.
    Clin Breast Cancer. 2017 Aug 10. pii: S1526-8209(17)30185.
    >> Share

  23. AZIM HA, Abdel-Malek R, Kassem L
    Predicting Brain Metastasis in Breast Cancer Patients: Stage Versus Biology.
    Clin Breast Cancer. 2017 Aug 18. pii: S1526-8209(17)30235.
    >> Share

  24. KOOL M, Bastiaannet E, Van de Velde CJH, Marang-van de Mheen PJ, et al
    Reliability of Self-reported Treatment Data by Patients With Breast Cancer Compared With Medical Record Data.
    Clin Breast Cancer. 2017 Aug 18. pii: S1526-8209(17)30212.
    >> Share

    Clin Cancer Res

  25. DIOT G, Metz S, Noske A, Liapis E, et al
    Multi-Spectral Optoacoustic Tomography (MSOT) of human breast cancer.
    Clin Cancer Res. 2017 Sep 12. pii: clincanres.3200.2016.
    >> Share

    Clin Exp Metastasis

  26. KHALIL AA, Ilina O, Gritsenko PG, Bult P, et al
    Collective invasion in ductal and lobular breast cancer associates with distant metastasis.
    Clin Exp Metastasis. 2017 Sep 11. doi: 10.1007/s10585-017-9858.
    >> Share

    Eur J Cancer

  27. MUCHOWICZ A, Wachowska M, Stachura J, Tonecka K, et al
    Inhibition of lymphangiogenesis impairs antitumour effects of photodynamic therapy and checkpoint inhibitors in mice.
    Eur J Cancer. 2017;83:19-27.
    >> Share


  28. LAHIRI DK, Maloney B, Sambamurti K
    When figures and data contradict text: MiR346 is apparently reduced in breast cancer tissue, contrary to claims by a paper's author.
    Gene. 2017 Sep 6. pii: S0378-1119(17)30646-7. doi: 10.1016/j.gene.2017.
    >> Share

    Genes Chromosomes Cancer

  29. WANG X, Teer JK, Tousignant RN, Levin AM, et al
    Breast cancer risk and germline genomic profiling of women with neurofibromatosis type 1 who developed breast cancer.
    Genes Chromosomes Cancer. 2017 Sep 10. doi: 10.1002/gcc.22503.
    >> Share

    Int J Cancer

  30. WANG S, Huo D, Kupfer S, Alleyne D, et al
    Genetic variation in the Vitamin D related pathway and breast cancer risk in women of African ancestry in the Root Consortium.
    Int J Cancer. 2017 Sep 10. doi: 10.1002/ijc.31038.
    >> Share

    Int J Oncol

  31. RATAJCZAK-WIELGOMAS K, Grzegrzolka J, Piotrowska A, Matkowski R, et al
    Expression of periostin in breast cancer cells.
    Int J Oncol. 2017;51:1300-1310.
    >> Share

  32. YIN H, Zhu Q, Liu M, Tu G, et al
    GPER promotes tamoxifen-resistance in ER+ breast cancer cells by reduced Bim proteins through MAPK/Erk-TRIM2 signaling axis.
    Int J Oncol. 2017;51:1191-1198.
    >> Share

  33. PHILLIPS SL, Williams CB, Zambrano JN, Williams CJ, et al
    Connexin 43 in the development and progression of breast cancer: What's the connection? (Review).
    Int J Oncol. 2017;51:1005-1013.
    >> Share

    Int J Radiat Oncol Biol Phys

  34. KRUL IM, Opstal-van Winden AWJ, Aleman BMP, Janus CPM, et al
    Breast Cancer Risk After Radiation Therapy for Hodgkin Lymphoma: Influence of Gonadal Hormone Exposure.
    Int J Radiat Oncol Biol Phys. 2017 Jul 18. pii: S0360-3016(17)33598.
    >> Share


  35. GIULIANO AE, Ballman KV, McCall L, Beitsch PD, et al
    Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial.
    JAMA. 2017;318:918-926.
    >> Share

    Breast Cancer Surgery: Less Is More.
    JAMA. 2017;318:909-911.
    >> Share

    NPJ Breast Cancer

  37. STEMMER SM, Steiner M, Rizel S, Soussan-Gutman L, et al
    Clinical outcomes in patients with node-negative breast cancer treated based on the recurrence score results: evidence from a large prospectively designed registry.
    NPJ Breast Cancer. 2017;3:33.
    >> Share

  38. STEMMER SM, Steiner M, Rizel S, Geffen DB, et al
    Clinical outcomes in ER+ HER2 -node-positive breast cancer patients who were treated according to the Recurrence Score results: evidence from a large prospectively designed registry.
    NPJ Breast Cancer. 2017;3:32.
    >> Share


  39. ROWSON-HODEL AR, Wald JH, Hatakeyama J, O'Neal WK, et al
    Membrane Mucin Muc4 promotes blood cell association with tumor cells and mediates efficient metastasis in a mouse model of breast cancer.
    Oncogene. 2017 Sep 11. doi: 10.1038/onc.2017.
    >> Share

    PLoS One

  40. LU S, Qian Y, Huang X, Yu H, et al
    The association of dietary pattern and breast cancer in Jiangsu, China: A population-based case-control study.
    PLoS One. 2017;12:e0184453.
    >> Share

  41. FUKADA I, Ito Y, Kobayashi K, Shibayama T, et al
    The early onset of peripheral neuropathy might be a robust predictor for time to treatment failure in patients with metastatic breast cancer receiving chemotherapy containing paclitaxel.
    PLoS One. 2017;12:e0184322.
    >> Share

  42. LEFTIN A, Ben-Chetrit N, Klemm F, Joyce JA, et al
    Iron imaging reveals tumor and metastasis macrophage hemosiderin deposits in breast cancer.
    PLoS One. 2017;12:e0184765.
    >> Share

  43. ZEIDAN AM, Long JB, Wang R, Hu X, et al
    Risk of myeloid neoplasms after radiotherapy among older women with localized breast cancer: A population-based study.
    PLoS One. 2017;12:e0184747.
    >> Share

  44. SU S, Bao H, Wang X, Wang Z, et al
    The quality of invasive breast cancer care for low reimbursement rate patients: A retrospective study.
    PLoS One. 2017;12:e0184866.
    >> Share

  45. POPOLIN CP, Reis JPB, Becceneri AB, Graminha AE, et al
    Cytotoxicity and anti-tumor effects of new ruthenium complexes on triple negative breast cancer cells.
    PLoS One. 2017;12:e0183275.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016